Post-Grant Review Of Oral Lisinopril Patent Sought By Drug Maker
ALEXANDRIA, Va. — In a July 10 petition for post-grant review (PGR), a pharmaceutical company and a limited liability company that bills itself as a “partner” in inter partes review proceedings...To view the full article, register now.
Already a subscriber? Click here to view full article